HK1087357A1 - Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1- propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder. - Google Patents

Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1- propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder.

Info

Publication number
HK1087357A1
HK1087357A1 HK06109619.6A HK06109619A HK1087357A1 HK 1087357 A1 HK1087357 A1 HK 1087357A1 HK 06109619 A HK06109619 A HK 06109619A HK 1087357 A1 HK1087357 A1 HK 1087357A1
Authority
HK
Hong Kong
Prior art keywords
estra
benzodioxol
dien
propynyl
hydroxy
Prior art date
Application number
HK06109619.6A
Other languages
English (en)
Inventor
Cornelis Sennef
B W M M Bernardus Peeters
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of HK1087357A1 publication Critical patent/HK1087357A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK06109619.6A 2001-10-26 2006-08-29 Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1- propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder. HK1087357A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01204072 2001-10-26

Publications (1)

Publication Number Publication Date
HK1087357A1 true HK1087357A1 (en) 2006-10-13

Family

ID=8181136

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06109619.6A HK1087357A1 (en) 2001-10-26 2006-08-29 Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1- propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder.

Country Status (27)

Country Link
US (1) US20040266863A1 (xx)
EP (2) EP1652526B1 (xx)
JP (1) JP4647909B2 (xx)
KR (1) KR20050038580A (xx)
CN (1) CN100531738C (xx)
AT (2) ATE420649T1 (xx)
AU (1) AU2002348996B2 (xx)
BR (1) BR0213466A (xx)
CA (1) CA2463446C (xx)
CY (1) CY1110173T1 (xx)
DE (2) DE60209248D1 (xx)
DK (1) DK1652526T3 (xx)
EC (1) ECSP045080A (xx)
ES (1) ES2319563T3 (xx)
HK (1) HK1087357A1 (xx)
HR (1) HRP20040370B1 (xx)
HU (1) HUP0500070A3 (xx)
IL (2) IL161248A0 (xx)
IS (1) IS2702B (xx)
MX (1) MXPA04003781A (xx)
NO (1) NO332978B1 (xx)
NZ (1) NZ532429A (xx)
PL (1) PL206687B1 (xx)
PT (1) PT1652526E (xx)
RU (1) RU2302245C2 (xx)
WO (1) WO2003037354A1 (xx)
ZA (1) ZA200403088B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080061A1 (en) * 2003-07-23 2005-04-14 Corcept Therapeutics, Inc. Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
MX2007006045A (es) * 2004-11-19 2007-06-13 Organon Nv Combinacion farmaceutica que comprende inhibidor selectivo de reabsorcion de serotonina y antagonista del receptor de glucocorticoide para tratamiento de depresion.
AU2011236053B2 (en) * 2004-11-19 2014-06-26 Merck Sharpe & Dohme B.V. Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
JP2009535430A (ja) * 2006-05-02 2009-10-01 コーセプト セラピューティクス, インコーポレイテッド Il−2を摂取している患者における抑うつを処置するためのグルココルチコイドレセプターiiアンタゴニストの使用
US8658128B2 (en) 2011-02-03 2014-02-25 Pop Test Cortisol Llc System and method for diagnosis and treatment
EP2699245A4 (en) * 2011-04-18 2014-12-10 Pop Test Cortisol Llc TREATMENT AGAINST HAIR LOSS
US8986677B2 (en) * 2012-07-30 2015-03-24 Pop Test Cortisol Llc Therapeutic compositions and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814333A (en) * 1987-07-28 1989-03-21 The Trustees Of Dartmouth College Method for treatment of hypercortisolemic, depressed patients
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
DE19727772A1 (de) * 1997-06-30 1999-01-28 Forschungszentrum Juelich Gmbh Magnetflußsensor mit ringförmiger Sonde
DE69835225T2 (de) * 1997-10-06 2007-07-05 The Board Of Trustees Of The Leland Stanford Junior University, Palo Alto Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen
DK1370268T3 (da) * 2001-03-23 2009-09-14 Corcept Therapeutics Inc Fremgangsmåde til behandling af stresssygdomme under anvendelse af glucocorticoid-receptor-specifikke antagonister
JP2005512949A (ja) * 2001-05-04 2005-05-12 コーセプト セラピューティクス, インコーポレイテッド グルココルチコイドレセプターに特異的なアンタゴニストを使用して、せん妄を処置する方法
IL160649A0 (en) * 2001-08-31 2004-07-25 Corcept Therapeutics Inc Methods for inhibiting cognitive deterioration in adults with down syndrome

Also Published As

Publication number Publication date
HUP0500070A2 (hu) 2005-04-28
ES2319563T3 (es) 2009-05-08
CA2463446A1 (en) 2003-05-08
CA2463446C (en) 2010-02-23
ATE420649T1 (de) 2009-01-15
IL161248A0 (en) 2004-09-27
BR0213466A (pt) 2004-11-09
CN100531738C (zh) 2009-08-26
NZ532429A (en) 2004-10-29
US20040266863A1 (en) 2004-12-30
RU2004116082A (ru) 2005-05-10
NO20041651L (no) 2004-04-23
RU2302245C2 (ru) 2007-07-10
KR20050038580A (ko) 2005-04-27
CY1110173T1 (el) 2015-01-14
EP1441739B1 (en) 2006-02-15
HRP20040370B1 (en) 2012-09-30
AU2002348996B2 (en) 2008-06-05
EP1652526B1 (en) 2009-01-14
DE60230936D1 (de) 2009-03-05
IS7204A (is) 2004-03-31
PL206687B1 (pl) 2010-09-30
MXPA04003781A (es) 2004-07-30
JP2005521637A (ja) 2005-07-21
EP1441739A1 (en) 2004-08-04
NO332978B1 (no) 2013-02-11
DE60209248D1 (de) 2006-04-20
JP4647909B2 (ja) 2011-03-09
ECSP045080A (es) 2004-06-28
PT1652526E (pt) 2009-02-06
IL161248A (en) 2010-12-30
DK1652526T3 (da) 2009-05-18
WO2003037354A1 (en) 2003-05-08
CN1582153A (zh) 2005-02-16
PL369261A1 (en) 2005-04-18
HUP0500070A3 (en) 2012-09-28
ATE317700T1 (de) 2006-03-15
HRP20040370A2 (en) 2004-08-31
ZA200403088B (en) 2005-01-24
IS2702B (is) 2010-11-15
EP1652526A3 (en) 2006-08-02
EP1652526A2 (en) 2006-05-03

Similar Documents

Publication Publication Date Title
HK1087357A1 (en) Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1- propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder.
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
UA83620C2 (ru) Замещенные бензоксазолы и их аналоги как эстрогенные агенты
CY1104981T1 (el) Χρηση των αντιπρογεστερονων για προληψη και αντιμετωπιση των εξαρτωμενων απο ορμονες ασθενειων
PL345955A1 (en) PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
ES2124905T3 (es) Esteroides antiglucocorticoides destinados al tratamiento de trastornos de ansiedad.
SG153645A1 (en) Hormone replacement therapy
MXPA04005784A (es) 2-fenilbenzofuranos sustituidos como agentes estrogenitos.
IL159714A (en) Pharmaceutical composition for oral delivery comprising a fragment of parathyroid hormone and 5-cnac
HUP0500346A2 (hu) Konjugált ösztrogének alkalmazása ösztrogénpótó terápiában hatásos gyógyszerkészítmények előállítására
HUP0402028A3 (en) Unsaturated 1-amino-alkylcyclohexane derivatives, pharmaceutical compositions containing them and use thereof
IL133632A (en) Use of a specific 5ht2 receptor antagonist for the preparation of pharmaceutical compositions useful in the treatment of the sleep apnea syndrome
WO2002074315A8 (de) Pharmazeutische kombinationspräparate enthaltend aromatasehemmer und substanzen mit estrogener wirkung sowie ihre verwendung zur herstellung eines medikaments zur estrogen-ersatz-therapie
EA200501739A1 (ru) Композиция, содержащая антагонисты рецептора прогестерона и чистые антиэстрогены, предназначенные для профилактики и лечения гормонзависимых заболеваний
RS50350B (sr) Upotreba 11beta-(4-acetilfenil)-17beta-hidroksi-17alfa-(1,1,2,2,2-pentafluoretil)estra-4,9-dien-3-ona za pripremanje medikamenta za lečenje kancera dojke, jajnika, endometrijuma, mijeloma i meningioma
HK1070900A1 (en) Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds
ZA200110073B (en) 14β-H-Sterols, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments.
NO20022712D0 (no) Umettede 14,15-syklopropanandrostaner, fremgangsmåte for deres fremstilling, og farmasöytiske preparater som inneholderdisse forbindelsene
BR0304292A (pt) Preparado de combinação de estrogênio-gestagênio e uso
TW200733955A (en) Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20131021